THURSDAY, April 6, 2023 (HealthDay News) — An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show. The vaccine is 86% effective in protecting older adults against RSV infections severe enough to cause three or more symptoms, according to findingsContinue Reading

FRIDAY, March 31, 2023 (HealthDay News) — Prescriptions for attention deficit hyperactivity disorder (ADHD) medications spiked during the COVID-19 pandemic, a new government report shows. The trend may reflect both greater awareness among adults of ADHD symptoms and increased stress driving people to get the care they need. “This reportContinue Reading